文献速递区域麻醉与超声

外周神经阻滞研究中有创安慰剂使用的随访研究

Invasive placebos in research on peripheral nerve blocks: a follow-up study.
PubMed 文献 · Reg Anesth Pain Med · 2021-04-09

该随访研究对外周神经阻滞随机对照研究进行SHAM分级,发现SHAM≥3的研究占33.3%,低于2011年原研究的52%;无儿科研究达到SHAM≥3。

要点

  • 外周神经阻滞研究中有创安慰剂高风险使用较前下降
  • SHAM≥3研究占33.3%,对照组累计1494例患者
  • 儿科研究均未使用SHAM≥3的有创安慰剂

核心结论

  • 当代外周神经阻滞研究中使用可能伴随严重风险的有创安慰剂已减少。

研究设计与样本

  • 重复原研究,对22个月期间发表的英文外周神经阻滞随机对照研究进行SHAM分级。

主要发现

  • 共纳入114项研究,其中儿科5项、成人109项。
  • SHAM≥3的研究38项(33.3%),这些对照组累计1494例患者。
  • 多项研究讨论了选择非侵入性安慰剂的理由,无儿科研究SHAM≥3。

关键数值与推荐

  • SHAM分级从0(无潜在并发症)到4(有严重并发症风险)。
  • 原2011年研究发现52%的外周神经阻滞研究SHAM≥3。

临床怎么用

  • 提示研究者在外周神经阻滞试验中应审慎选择安慰剂,优先考虑非侵入性方式以降低风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The Serious Harm and Morbidity "SHAM" grading system has previously been proposed to categorize the risks associated with the use of invasive placebos in peripheral nerve block research. SHAM grades range from 0 (no potential complications, eg, using standard analgesia techniques as a comparator) through to 4 (risk of major complications, eg, performing a sub-Tenon's block and injecting normal saline). A study in 2011 found that 52% of studies of peripheral nerve blocks had SHAM grades of 3 or more. METHODS: We repeated the original study by allocating SHAM grades to randomized controlled studies of peripheral nerve blocks published in English over a 22-month period. Documentation was made of the number of study participants, age, number of controls, body region, adverse events due to invasive placebos and any discussion regarding the ethics of using invasive placebos. We compared the proportion of studies with SHAM grades of 3 or more with the original study. RESULTS: In this current study, 114 studies fulfilled the inclusion criteria, 5 pediatric and 109 adult. The SHAM grade was ≥3 in 38 studies (33.3%), with 1494 patients in these control groups collectively. Several studies discussed their reasons for choosing a non-invasive placebo. No pediatric studies had a SHAM grade of ≥3. CONCLUSIONS: The use of invasive placebos that may be associated with serious risks in peripheral nerve block research has decreased in contemporary peripheral nerve block research.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Laing S, Bolt DL, Burgoyne LL, et al. Invasive placebos in research on peripheral nerve blocks: a follow-up study. Reg Anesth Pain Med. 2021. PMID: 33837140. doi:10.1136/rapm-2021-102474

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。